Bio-Rad Bio-Plex 3D Suspension Array System
| Brand | Bio-Rad |
|---|---|
| Origin | USA |
| Manufacturer Type | Authorized Distributor |
| Origin Category | Imported |
| Model | Bio-Plex 3D |
| Pricing | Available Upon Request |
Overview
The Bio-Rad Bio-Plex 3D Suspension Array System is a high-throughput, flow-based multiplex immunoassay platform engineered for quantitative detection of up to 500 distinct analytes in a single microliter-scale sample. Built upon Luminex xMAP® technology, the system utilizes spectrally distinct fluorescently dyed microspheres (beads), each conjugated to a unique capture molecule—antibody, antigen, oligonucleotide, or receptor—enabling simultaneous measurement via dual-laser interrogation. The Bio-Plex 3D integrates an upgraded fluidics architecture, enhanced optical detection sensitivity, and expanded dynamic range compared to prior-generation platforms, supporting rigorous translational research and regulated bioanalytical workflows. Its design emphasizes assay scalability, reproducibility across laboratories, and compatibility with standardized biosample matrices—including serum, plasma, cerebrospinal fluid, cell culture supernatants, and tissue lysates.
Key Features
- High-plex capability: Quantitative profiling of up to 500 analytes per well in 96- or 384-well microplate format
- Dual-laser optical detection: Separation of bead identity (classification laser at 635 nm) and reporter signal intensity (quantitation laser at 532 nm) with <1% coefficient of variation (CV) for intra-assay precision
- Enhanced fluidics module: Reduced carryover (<0.01%), improved bead resuspension uniformity, and optimized aspiration/dispense kinetics for low-volume samples (≥10 µL)
- Integrated calibration and QC tracking: On-board reference standards, daily performance verification kits, and automated drift correction algorithms
- Regulatory-ready architecture: Compliant with instrument qualification protocols per ISO/IEC 17025 and aligned with FDA 21 CFR Part 11 requirements for electronic records and signatures when deployed with validated software configurations
Sample Compatibility & Compliance
The Bio-Plex 3D supports native and processed biological specimens without requirement for pre-fractionation or amplification. Validated sample types include human and non-human primate serum/plasma (EDTA, heparin, citrate), bronchoalveolar lavage fluid, synovial fluid, and clarified cell lysates. All assays are developed under Good Laboratory Practice (GLP) principles and referenced against NIST-traceable calibrators where available. Platform-level validation documentation—including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) templates—is provided to support GxP environments. The system meets CE-IVD marking requirements for in vitro diagnostic use in the European Economic Area and conforms to IEC 61010-1 safety standards for laboratory equipment.
Software & Data Management
Bio-Plex Manager™ MP Software v6.2 or later provides end-to-end workflow control—from plate layout definition and instrument method setup to real-time acquisition monitoring and automated standard curve fitting (4- or 5-parameter logistic regression). Raw data export is supported in .csv, .txt, and compliant .xml formats compatible with third-party statistical packages (e.g., R, GraphPad Prism, SAS). Audit trail functionality logs all user actions, parameter modifications, and data reprocessing events with timestamp, operator ID, and reason-for-change fields—fully traceable for GLP/GMP audits. Secure role-based access control (RBAC) allows configuration of administrator, analyst, and reviewer permissions consistent with 21 CFR Part 11 Annex 11 expectations.
Applications
- Immunoprofiling: Cytokine, chemokine, growth factor, and autoantibody panels in autoimmune disease, oncology, and vaccine response studies
- Pharmacodynamic biomarker monitoring: Longitudinal tracking of soluble mediators in clinical trial biospecimens
- Host-pathogen interaction analysis: Simultaneous quantification of pathogen antigens and host immune effectors
- Cell signaling pathway mapping: Phosphoprotein and total protein co-detection using matched antibody pairs
- Nucleic acid-based applications: Multiplexed miRNA expression profiling and SNP genotyping via hybridization-coupled bead arrays
FAQ
Is the Bio-Plex 3D compatible with legacy Bio-Plex 200 assay kits?
Yes—Bio-Plex 3D maintains full backward compatibility with all Bio-Plex Pro™, Bio-Plex Custom, and Bio-Plex Certified assay kits designed for the Bio-Plex 200 platform.
What validation support is included for regulated environments?
Bio-Rad provides IQ/OQ/PQ documentation templates, installation services by certified field application specialists, and optional 21 CFR Part 11 compliance packages including electronic signature modules and audit trail configuration reports.
Can the system be integrated into automated liquid handling workflows?
Yes—the Bio-Plex 3D features ANSI/SLAS-compliant deck dimensions and bidirectional RS-232/Ethernet communication protocols, enabling integration with major robotic platforms (e.g., Tecan Freedom EVO, Hamilton STAR) via Bio-Plex Manager’s API interface.
Does Bio-Rad offer assay development support for custom panels?
Yes—Bio-Rad’s Custom Assay Services group provides end-to-end development, optimization, and analytical validation of proprietary multiplex panels, including conjugation chemistry, bead coupling efficiency testing, and inter-laboratory reproducibility assessment.
